T
Power Law company profile
TransThera Biosciences
Biotech & Life Sciences · Nanjing City, China · Founded 2016 · IPO 2025 Unicorn
Valuation
$629M
Market cap · 2026
Revenue
$7.4M
Latest reported FY
Global footprint
Where TransThera Biosciences has talent and traffic
Web traffic by country
200
monthly visits
across markets
across markets
🇩🇪 Germany100%
Patent intelligence
$73M patent portfolio · 79 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$73M
11.6% of market cap · 1.6× smaller than top peer Constellation Pharmaceuticals ($116M)
79 active patent families
Where TransThera Biosciences innovates
Pharmaceutical medicinePharmaceutical drugDiseaseMedicinal chemistryStereoisomerism
Above peer median on Technology
Quality vs same-sector peers
TransThera Biosciences on the five Patsnap quality dimensions
TransThera Biosciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where TransThera Biosciences concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across TransThera Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee TransThera Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.